Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukimia
The 309T>G polymorphism in the promoter region of the MDM2 gene, known as SNP309, has recently been suggested as an unfavorable prognostic marker in chronic lymphocytic leukemia (CLL) although this has been questioned. To investigate this further, we analyzed the MDM2 SNP309 genotypes in 418 CLL...
Main Authors: | Kaderi, Mohd Arifin, Mansouri, Mahmoud, Zainuddin, Norafiza, Cahill, Nicola, Gunnarsson, Rebeqa, Jansson, Mattias, Kimby, Eva, Aleskog, Anna, Lundin, Jeanette, Glimelius, Bengt, Melbye, Mads, Juliusson, Gunnar, Jesper Jurlander, Jesper, Rosenquist, Richard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/4408/ http://irep.iium.edu.my/4408/ http://irep.iium.edu.my/4408/ http://irep.iium.edu.my/4408/1/Paper_III_Norafiza_Zainuddin.pdf |
Similar Items
-
TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia
by: Zainuddin, Norafiza, et al.
Published: (2011) -
TP53 mutations are infrequent in newly diagnosed chronic lymphocytic leukimia
by: Zainuddin, Norafiza, et al.
Published: (2011) -
The MDM2 polymorphism SNP309 is associated with clinical characteristics and outcome in diffuse large B-cell lymphoma
by: Hedstrom, Gustav, et al.
Published: (2014) -
Cytotoxicity effect of melastoma malabatricum on skin melanoma and cervical cancer in vitro
by: Ahmad Roslen, Nurfariza, et al.
Published: (2013) -
MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis
by: Benner, Axel, et al.
Published: (2014)